Investor Information
Financial Filings
SEDAR Filings (System for Electronic Document Analysis and Retrieval)
Fiscal Year 2024
-
Q124 Unaudited Condensed Consolidated Interim Financial Statements - March 31, 2024 -
Q124 FY23 Management Discussion & Analysis - March 31, 2024
Fiscal Year 2023
-
FY23 Audited Consolidated Financial Statements - December 31, 2023
-
FY23 Managements Discussion & Analysis - December 31, 2023
-
3Q23 Condensed Interim Consolidated Financial Statements – September 2023
-
3Q23 Management Discussion & Analysis –September2023
-
2Q23 Condensed Interim Consolidated Financial Statements – June 2023
-
2Q23 Management Discussion & Analysis – June 2023
-
1Q23 Condensed Interim Consolidated Financial Statements – March 2023
-
1Q23 Management Discussion & Analysis – March 2023
Fiscal Year 2022
-
FY22 Audited Consolidated Financial Statements - December 2022
-
FY22 Management Discussion & Analysis – December 2022
-
3Q22 Condensed Interim Consolidated Financial Statements – September 2022
-
3Q22 Management Discussion & Analysis – September 2022
-
2Q22 Condensed Interim Consolidated Financial Statements – June 2022
-
2Q22 Management Discussion & Analysis – June 2022
-
1Q22 Condensed Interim Consolidated Financial Statements – March 2022
-
1Q22 Management Discussion & Analysis – March 2022
Fiscal Year 2021
-
FY21 Audited Consolidated Financial Statements – December 2021
-
FY21 Management Discussion & Analysis - December 2021
-
3Q21 Condensed Interim Consolidated Financial Statements – September 2021
-
3Q21 Management Discussion & Analysis - September 2021
-
2Q21 Condensed Interim Consolidated Financial Statements – June 2021
-
2Q21 Management Discussion & Analysis – June 2021
-
1Q21 Condensed Interim Consolidated Financial Statements – March 2021
-
1Q21 Management Discussion & Analysis – March 2021
Fiscal Year 2020
-
FY20 Audited Consolidated Financial Statements – December 2020
-
FY20 Management Discussion & Analysis – December 2020
-
3Q20 Condensed Interim Consolidated Financial Statements – September 2020
-
3Q20 Management Discussion & Analysis – September 2020
-
2Q20 Condensed Interim Consolidated Financial Statements – June 2020
-
2Q20 Management Discussion & Analysis – June 2020
-
1Q20 Condensed Interim Consolidated Financial Statements – March 2020
-
1Q20 Management Discussion & Analysis – March 2020
Fiscal Year 2019
-
FY19 Audited Consolidated Financial Statements – December 2019
-
FY19 Management Discussion & Analysis – December 2019
-
3Q19 Condensed Interim Consolidated Financial Statements – September 2019
-
3Q19 Management Discussion & Analysis – September 2019
-
2Q19 Condensed Interim Consolidated Financial Statements – June 2019
-
2Q19 Management Discussion & Analysis – June 2019
-
1Q19 Condensed Interim Consolidated Financial Statements – March 2019
-
1Q19 Management Discussion & Analysis – March 2019
Fiscal Year 2018
-
FY18 Audited Consolidated Financial Statements – December 2018
-
FY18 Management Discussion & Analysis – December 2018
-
3Q18 Condensed Interim Consolidated Financial Statements – September 2018
-
3Q18 Management Discussion & Analysis – September 2018
-
2Q18 Condensed Interim Consolidated Financial Statements – June 2018
-
2Q18 Management Discussion & Analysis – June 2018
-
1Q18 Condensed Interim Consolidated Financial Statements – March 2018
-
1Q18 Management Discussion & Analysis – March 2018
Fiscal Year 2017
-
FY17 Audited Consolidated Financial Statements – December 2017
-
FY17 Management Discussion & Analysis – December 2017
-
3Q17 Condensed Interim Consolidated Financial Statements – September 2017
-
3Q17 Management Discussion & Analysis – September 2017
-
2Q17 Condensed Interim Consolidated Financial Statements – June 2017
-
2Q17 Management Discussion & Analysis – June 2017
-
1Q17 Condensed Interim Consolidated Financial Statements – March 2017
-
1Q17 Management Discussion & Analysis – March 2017
Fiscal Year 2016
-
FY16 Audited Consolidated Financial Statements – December 2016
-
FY16 Management Discussion & Analysis – December 2016
-
3Q16 Condensed Interim Consolidated Financial Statements – September 2016
-
3Q16 Management Discussion & Analysis – September 2016
-
2Q16 Condensed Interim Consolidated Financial Statements (Amended) – June 2016
-
2Q16 Management Discussion & Analysis (Amended) – June 2016
-
1Q16 Condensed Interim Consolidated Financial Statements (Amended) – March 2016
-
1Q16 Management Discussion & Analysis – June 2016
Fiscal Year 2015
-
FY15 Audited Consolidated Financial Statements – December 2015
-
FY15 Management Discussion & Analysis – December 2015
-
3Q15 Condensed Interim Consolidated Financial Statements – September 2015
-
3Q15 Management Discussion & Analysis – September 2015
-
2Q15 Condensed Interim Consolidated Financial Statements – June 2015
-
2Q15 Management Discussion & Analysis – June 2015
-
1Q15 Condensed Interim Consolidated Financial Statements – March 2015
-
1Q15 Management Discussion & Analysis – March 2015
Our Partners
As part of our continuing mission to design, develop, and manufacture cutting-edge laser technologies, Theralase® has partnered with individuals and groups at the following institutions and organizations.
